close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PerkinElmer (NY:PKI)

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about PerkinElmer

< Previous 1 2 3 Next >
Revvity Announces Financial Results for the First Quarter of 2023
From Revvity, Inc.
Via Business Wire
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
From Revvity, Inc.
Via Business Wire
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
From PerkinElmer Inc.
Via Business Wire
PerkinElmer to Present at J.P. Morgan Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
From PerkinElmer Inc.
Via Business Wire
PerkinElmer to Present at 2022 Stifel Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Announces Financial Results for the Third Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
From PerkinElmer
Via Business Wire
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer Inc.
Via Business Wire
PerkinElmer Announces Finance Leadership Transition
From PerkinElmer, Inc.
Via Business Wire
New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
From New Mountain Capital
Via Business Wire
PerkinElmer Announces Financial Results for the Second Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
From PerkinElmer, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today